 Carol Sartorius
Concepts (313)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Breast Neoplasms | 50 | 2022 | 1870 | 6.370 |
Why?
| | Receptors, Progesterone | 34 | 2020 | 319 | 5.480 |
Why?
| | Progesterone | 14 | 2021 | 232 | 3.800 |
Why?
| | Keratin-5 | 9 | 2022 | 46 | 3.470 |
Why?
| | Receptors, Estrogen | 26 | 2022 | 372 | 2.960 |
Why?
| | Progestins | 12 | 2021 | 75 | 2.660 |
Why?
| | Neoplastic Stem Cells | 12 | 2020 | 334 | 2.470 |
Why?
| | Estrogens | 9 | 2018 | 312 | 1.730 |
Why?
| | Cell Line, Tumor | 25 | 2022 | 2725 | 1.390 |
Why?
| | Estrogen Receptor alpha | 5 | 2022 | 121 | 1.240 |
Why?
| | Receptors, Androgen | 5 | 2021 | 131 | 0.940 |
Why?
| | Gene Expression Regulation, Neoplastic | 16 | 2022 | 1148 | 0.940 |
Why?
| | Xenograft Model Antitumor Assays | 10 | 2020 | 706 | 0.860 |
Why?
| | Keratin-17 | 1 | 2022 | 4 | 0.840 |
Why?
| | Drug Resistance, Neoplasm | 8 | 2020 | 642 | 0.810 |
Why?
| | Estradiol | 8 | 2016 | 455 | 0.790 |
Why?
| | Biomarkers, Tumor | 8 | 2022 | 1054 | 0.770 |
Why?
| | Mammary Glands, Animal | 3 | 2012 | 116 | 0.730 |
Why?
| | Cell Proliferation | 14 | 2021 | 2199 | 0.690 |
Why?
| | Carcinoma, Lobular | 1 | 2020 | 44 | 0.690 |
Why?
| | Carcinoma, Ductal, Breast | 1 | 2020 | 77 | 0.680 |
Why?
| | Receptor, ErbB-2 | 4 | 2020 | 301 | 0.660 |
Why?
| | Mice | 33 | 2020 | 14935 | 0.640 |
Why?
| | Antineoplastic Agents, Hormonal | 10 | 2022 | 138 | 0.630 |
Why?
| | beta Catenin | 1 | 2020 | 220 | 0.600 |
Why?
| | Female | 51 | 2022 | 59571 | 0.600 |
Why?
| | Retinoic Acid Receptor alpha | 1 | 2017 | 11 | 0.580 |
Why?
| | RNA Polymerase III | 1 | 2017 | 25 | 0.580 |
Why?
| | Receptors, Retinoic Acid | 1 | 2017 | 50 | 0.570 |
Why?
| | Tamoxifen | 7 | 2020 | 192 | 0.560 |
Why?
| | Stem Cells | 2 | 2011 | 546 | 0.550 |
Why?
| | MicroRNAs | 4 | 2015 | 601 | 0.540 |
Why?
| | Triple Negative Breast Neoplasms | 2 | 2015 | 158 | 0.540 |
Why?
| | Tumor Suppressor Proteins | 2 | 2015 | 282 | 0.510 |
Why?
| | Neoplasms, Glandular and Epithelial | 1 | 2015 | 34 | 0.510 |
Why?
| | Mice, SCID | 6 | 2020 | 320 | 0.500 |
Why?
| | Paracrine Communication | 1 | 2015 | 56 | 0.500 |
Why?
| | Animals | 38 | 2022 | 31837 | 0.480 |
Why?
| | Neoplasms, Hormone-Dependent | 2 | 2012 | 38 | 0.470 |
Why?
| | STAT5 Transcription Factor | 1 | 2014 | 44 | 0.470 |
Why?
| | Humans | 64 | 2023 | 114925 | 0.470 |
Why?
| | Tumor Microenvironment | 7 | 2021 | 434 | 0.460 |
Why?
| | Cisplatin | 1 | 2015 | 263 | 0.460 |
Why?
| | Signal Transduction | 9 | 2021 | 4524 | 0.460 |
Why?
| | Astrocytes | 1 | 2015 | 162 | 0.450 |
Why?
| | Mice, Inbred NOD | 5 | 2020 | 561 | 0.440 |
Why?
| | Gene Expression Profiling | 13 | 2020 | 1523 | 0.440 |
Why?
| | Ovarian Neoplasms | 2 | 2015 | 388 | 0.430 |
Why?
| | Tumor Cells, Cultured | 10 | 2020 | 855 | 0.430 |
Why?
| | Transcriptome | 4 | 2020 | 728 | 0.420 |
Why?
| | Heterografts | 5 | 2020 | 117 | 0.410 |
Why?
| | Medroxyprogesterone Acetate | 2 | 2015 | 28 | 0.390 |
Why?
| | Mammary Glands, Human | 1 | 2011 | 60 | 0.380 |
Why?
| | Hyaluronan Receptors | 6 | 2014 | 91 | 0.360 |
Why?
| | MCF-7 Cells | 7 | 2022 | 105 | 0.360 |
Why?
| | Carcinogenesis | 2 | 2020 | 179 | 0.310 |
Why?
| | Brain Neoplasms | 1 | 2015 | 987 | 0.290 |
Why?
| | Antineoplastic Agents | 2 | 2015 | 1897 | 0.290 |
Why?
| | Estrogen Replacement Therapy | 1 | 2008 | 116 | 0.290 |
Why?
| | Androgens | 2 | 2021 | 167 | 0.280 |
Why?
| | Mice, Nude | 6 | 2015 | 635 | 0.270 |
Why?
| | Lymphatic Metastasis | 5 | 2017 | 281 | 0.260 |
Why?
| | Transplantation, Heterologous | 6 | 2016 | 183 | 0.250 |
Why?
| | Antigens, CD | 2 | 2020 | 443 | 0.250 |
Why?
| | Neoplasm Recurrence, Local | 2 | 2022 | 863 | 0.250 |
Why?
| | DNA-Binding Proteins | 3 | 2015 | 1317 | 0.250 |
Why?
| | Models, Theoretical | 1 | 2008 | 516 | 0.240 |
Why?
| | Apoptosis | 6 | 2017 | 2371 | 0.240 |
Why?
| | Promoter Regions, Genetic | 5 | 2017 | 1133 | 0.230 |
Why?
| | Cell Transformation, Neoplastic | 2 | 2016 | 312 | 0.230 |
Why?
| | Myosin Heavy Chains | 3 | 2001 | 177 | 0.230 |
Why?
| | Down-Regulation | 3 | 2015 | 596 | 0.220 |
Why?
| | Pharmacology, Clinical | 1 | 2023 | 8 | 0.220 |
Why?
| | Cyclic AMP | 3 | 1995 | 225 | 0.220 |
Why?
| | Nuclear Proteins | 2 | 2015 | 593 | 0.220 |
Why?
| | Mammary Neoplasms, Experimental | 2 | 2020 | 64 | 0.210 |
Why?
| | Disease Progression | 5 | 2021 | 2392 | 0.210 |
Why?
| | Neoplasm Transplantation | 3 | 2016 | 232 | 0.210 |
Why?
| | Mammary Neoplasms, Animal | 1 | 2022 | 28 | 0.210 |
Why?
| | Homeodomain Proteins | 3 | 2018 | 464 | 0.210 |
Why?
| | Vimentin | 1 | 2022 | 58 | 0.200 |
Why?
| | Gene Knockout Techniques | 2 | 2020 | 99 | 0.200 |
Why?
| | Cell-Free Nucleic Acids | 1 | 2022 | 28 | 0.200 |
Why?
| | Tumor Suppressor Protein p53 | 2 | 2015 | 447 | 0.190 |
Why?
| | Cell Division | 1 | 2003 | 759 | 0.190 |
Why?
| | Doxorubicin | 1 | 2022 | 286 | 0.190 |
Why?
| | Transcription Factors | 5 | 2023 | 1530 | 0.190 |
Why?
| | Insulin Receptor Substrate Proteins | 1 | 2020 | 56 | 0.180 |
Why?
| | Leukocytes, Mononuclear | 2 | 2020 | 496 | 0.180 |
Why?
| | Transcription, Genetic | 6 | 2020 | 1317 | 0.180 |
Why?
| | Neoplasm Metastasis | 2 | 2020 | 530 | 0.180 |
Why?
| | Thyroid Hormones | 1 | 2020 | 54 | 0.180 |
Why?
| | Saccharomyces cerevisiae Proteins | 2 | 2001 | 333 | 0.180 |
Why?
| | Antigens, Nuclear | 1 | 2000 | 19 | 0.180 |
Why?
| | Protein Isoforms | 3 | 2019 | 338 | 0.170 |
Why?
| | Adherens Junctions | 1 | 2020 | 26 | 0.170 |
Why?
| | Neoplastic Cells, Circulating | 1 | 2020 | 59 | 0.170 |
Why?
| | Hormone Replacement Therapy | 1 | 2020 | 77 | 0.170 |
Why?
| | Poly(ADP-ribose) Polymerases | 1 | 2000 | 88 | 0.170 |
Why?
| | Neoplasm Invasiveness | 3 | 2020 | 445 | 0.170 |
Why?
| | Immunoprecipitation | 1 | 2020 | 152 | 0.170 |
Why?
| | Cluster Analysis | 4 | 2019 | 460 | 0.170 |
Why?
| | Up-Regulation | 2 | 2020 | 812 | 0.170 |
Why?
| | Forkhead Box Protein O1 | 1 | 2019 | 15 | 0.170 |
Why?
| | Protein Interaction Mapping | 1 | 2020 | 101 | 0.160 |
Why?
| | Epithelial-Mesenchymal Transition | 1 | 2020 | 168 | 0.160 |
Why?
| | DNA Helicases | 1 | 2000 | 134 | 0.160 |
Why?
| | Disease Susceptibility | 1 | 2021 | 316 | 0.160 |
Why?
| | Tretinoin | 2 | 2017 | 125 | 0.160 |
Why?
| | Lipid Metabolism | 1 | 2021 | 446 | 0.160 |
Why?
| | Mass Spectrometry | 2 | 2020 | 633 | 0.160 |
Why?
| | Cadherins | 1 | 2020 | 176 | 0.160 |
Why?
| | Wnt Signaling Pathway | 1 | 2020 | 147 | 0.150 |
Why?
| | Risk | 1 | 2021 | 815 | 0.150 |
Why?
| | Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2018 | 51 | 0.150 |
Why?
| | Lipids | 1 | 2021 | 582 | 0.150 |
Why?
| | Cell Culture Techniques | 1 | 2020 | 344 | 0.150 |
Why?
| | Single-Cell Analysis | 1 | 2019 | 189 | 0.140 |
Why?
| | 8-Bromo Cyclic Adenosine Monophosphate | 2 | 1994 | 17 | 0.140 |
Why?
| | Cancer-Associated Fibroblasts | 1 | 2016 | 10 | 0.140 |
Why?
| | Disease Models, Animal | 4 | 2016 | 3549 | 0.140 |
Why?
| | Glucose Transporter Type 1 | 1 | 2016 | 42 | 0.140 |
Why?
| | Sequence Analysis, RNA | 1 | 2019 | 390 | 0.140 |
Why?
| | Phenylthiohydantoin | 1 | 2016 | 40 | 0.140 |
Why?
| | ErbB Receptors | 2 | 2020 | 561 | 0.140 |
Why?
| | Cell Membrane | 1 | 2020 | 679 | 0.130 |
Why?
| | Tissue Array Analysis | 1 | 2015 | 50 | 0.130 |
Why?
| | CD146 Antigen | 3 | 2021 | 35 | 0.130 |
Why?
| | Ribosomal Proteins | 1 | 2015 | 70 | 0.130 |
Why?
| | Mutation | 4 | 2022 | 3353 | 0.130 |
Why?
| | Transcriptional Activation | 3 | 2006 | 337 | 0.120 |
Why?
| | Liver Neoplasms | 1 | 2019 | 509 | 0.120 |
Why?
| | Azepines | 1 | 2015 | 74 | 0.120 |
Why?
| | Neoadjuvant Therapy | 2 | 2021 | 305 | 0.120 |
Why?
| | Phenotype | 4 | 2011 | 2817 | 0.120 |
Why?
| | Binding Sites | 6 | 2016 | 1176 | 0.120 |
Why?
| | Gene Knockdown Techniques | 1 | 2015 | 299 | 0.120 |
Why?
| | Molecular Sequence Data | 7 | 2012 | 2791 | 0.120 |
Why?
| | Endometrial Neoplasms | 1 | 2015 | 141 | 0.110 |
Why?
| | Glycoproteins | 1 | 2015 | 305 | 0.110 |
Why?
| | Muscle, Skeletal | 3 | 2001 | 1472 | 0.110 |
Why?
| | RNA, Messenger | 2 | 2019 | 2558 | 0.110 |
Why?
| | Peptide Fragments | 3 | 2003 | 668 | 0.110 |
Why?
| | Immunohistochemistry | 2 | 2015 | 1635 | 0.110 |
Why?
| | Ligands | 3 | 2023 | 565 | 0.110 |
Why?
| | Gene Regulatory Networks | 2 | 2012 | 228 | 0.110 |
Why?
| | Oligonucleotide Array Sequence Analysis | 2 | 2012 | 744 | 0.110 |
Why?
| | Chromatin | 1 | 2016 | 428 | 0.110 |
Why?
| | CD24 Antigen | 1 | 2012 | 20 | 0.100 |
Why?
| | Mifepristone | 3 | 2020 | 60 | 0.100 |
Why?
| | Breast Neoplasms, Male | 1 | 2012 | 29 | 0.100 |
Why?
| | Retinoids | 1 | 2012 | 31 | 0.100 |
Why?
| | Cell Survival | 1 | 2015 | 1022 | 0.100 |
Why?
| | Cell Differentiation | 2 | 2012 | 1699 | 0.100 |
Why?
| | Pyrimidines | 1 | 2015 | 378 | 0.100 |
Why?
| | Kruppel-Like Transcription Factors | 1 | 2012 | 61 | 0.100 |
Why?
| | Small Molecule Libraries | 1 | 2012 | 80 | 0.100 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 1 | 2012 | 157 | 0.100 |
Why?
| | Tumor Burden | 1 | 2012 | 262 | 0.100 |
Why?
| | Drug Discovery | 1 | 2012 | 124 | 0.090 |
Why?
| | Cell Movement | 1 | 2015 | 867 | 0.090 |
Why?
| | Receptors, Notch | 1 | 2011 | 85 | 0.090 |
Why?
| | HeLa Cells | 4 | 2006 | 562 | 0.090 |
Why?
| | Peptides | 1 | 2015 | 848 | 0.090 |
Why?
| | Cell Size | 1 | 2010 | 81 | 0.090 |
Why?
| | HEK293 Cells | 1 | 2012 | 591 | 0.090 |
Why?
| | Peritoneal Neoplasms | 1 | 2010 | 54 | 0.090 |
Why?
| | Ovariectomy | 1 | 2010 | 116 | 0.090 |
Why?
| | Transforming Growth Factor beta | 1 | 2012 | 449 | 0.080 |
Why?
| | Adenocarcinoma | 1 | 2015 | 801 | 0.080 |
Why?
| | Cell Growth Processes | 2 | 2006 | 51 | 0.080 |
Why?
| | Flow Cytometry | 1 | 2012 | 1087 | 0.080 |
Why?
| | Embryonal Carcinoma Stem Cells | 1 | 2008 | 2 | 0.080 |
Why?
| | Muscle Fibers, Skeletal | 2 | 2001 | 185 | 0.080 |
Why?
| | Neoplasms, Experimental | 1 | 2008 | 152 | 0.070 |
Why?
| | Phosphorylation | 3 | 2008 | 1572 | 0.070 |
Why?
| | Kaplan-Meier Estimate | 2 | 2020 | 817 | 0.070 |
Why?
| | Lung Neoplasms | 1 | 2019 | 2222 | 0.070 |
Why?
| | Obesity | 1 | 2018 | 2514 | 0.070 |
Why?
| | Histone Acetyltransferases | 1 | 2006 | 51 | 0.060 |
Why?
| | Amino Acid Sequence | 3 | 2012 | 1988 | 0.060 |
Why?
| | Keratins | 1 | 2005 | 176 | 0.060 |
Why?
| | Models, Biological | 2 | 2008 | 1630 | 0.060 |
Why?
| | Organ Specificity | 2 | 2010 | 270 | 0.060 |
Why?
| | Chloramphenicol O-Acetyltransferase | 2 | 1994 | 38 | 0.060 |
Why?
| | Gonanes | 2 | 1994 | 27 | 0.060 |
Why?
| | Lymph Nodes | 1 | 2006 | 425 | 0.060 |
Why?
| | Mice, Transgenic | 2 | 2020 | 1953 | 0.060 |
Why?
| | Mice, Knockout | 2 | 2020 | 2586 | 0.050 |
Why?
| | Gene Expression Regulation | 2 | 2022 | 2324 | 0.050 |
Why?
| | Genes, Reporter | 2 | 2012 | 257 | 0.050 |
Why?
| | Hepatocyte Nuclear Factor 3-alpha | 1 | 2022 | 9 | 0.050 |
Why?
| | Base Sequence | 3 | 2001 | 2118 | 0.050 |
Why?
| | Neoplasm Proteins | 1 | 2005 | 385 | 0.050 |
Why?
| | Neoplasms | 1 | 2015 | 2106 | 0.050 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 1 | 2023 | 193 | 0.050 |
Why?
| | Aromatase Inhibitors | 1 | 2021 | 49 | 0.050 |
Why?
| | Nuclear Receptor Coactivator 3 | 1 | 2021 | 6 | 0.050 |
Why?
| | Nucleosomes | 1 | 2022 | 122 | 0.050 |
Why?
| | Cyclin-Dependent Kinase 4 | 1 | 2021 | 33 | 0.050 |
Why?
| | Cell Adhesion Molecules | 1 | 2021 | 168 | 0.050 |
Why?
| | Cyclin-Dependent Kinase 6 | 1 | 2021 | 37 | 0.050 |
Why?
| | DNA-Activated Protein Kinase | 1 | 2000 | 11 | 0.040 |
Why?
| | Ku Autoantigen | 1 | 2000 | 13 | 0.040 |
Why?
| | Antigens, Neoplasm | 1 | 2021 | 222 | 0.040 |
Why?
| | Glutathione Transferase | 1 | 2000 | 94 | 0.040 |
Why?
| | Cell Nucleus | 2 | 2016 | 554 | 0.040 |
Why?
| | Methionine | 1 | 2000 | 144 | 0.040 |
Why?
| | Carrier Proteins | 1 | 2023 | 696 | 0.040 |
Why?
| | B7-H1 Antigen | 1 | 2020 | 142 | 0.040 |
Why?
| | Prognosis | 2 | 2020 | 3344 | 0.040 |
Why?
| | Cell Death | 1 | 2020 | 325 | 0.040 |
Why?
| | Disease-Free Survival | 1 | 2020 | 623 | 0.040 |
Why?
| | Adult | 2 | 2017 | 30604 | 0.040 |
Why?
| | Gene Library | 1 | 2019 | 114 | 0.040 |
Why?
| | Datasets as Topic | 1 | 2019 | 98 | 0.040 |
Why?
| | Immunologic Memory | 1 | 2020 | 313 | 0.040 |
Why?
| | DNA, Complementary | 1 | 2019 | 257 | 0.040 |
Why?
| | Loss of Function Mutation | 1 | 2018 | 36 | 0.040 |
Why?
| | Breast | 1 | 2019 | 141 | 0.040 |
Why?
| | Diaphragm | 1 | 1998 | 32 | 0.040 |
Why?
| | Protein Biosynthesis | 1 | 2000 | 385 | 0.040 |
Why?
| | Mice, Inbred BALB C | 1 | 2020 | 1152 | 0.040 |
Why?
| | Sequence Homology, Amino Acid | 2 | 2012 | 353 | 0.040 |
Why?
| | Myosins | 1 | 1998 | 128 | 0.040 |
Why?
| | Dendritic Cells | 1 | 2020 | 436 | 0.040 |
Why?
| | Mutagenesis, Site-Directed | 2 | 2001 | 345 | 0.040 |
Why?
| | Heterozygote | 1 | 1998 | 251 | 0.040 |
Why?
| | Recombinant Fusion Proteins | 1 | 2000 | 617 | 0.040 |
Why?
| | Protein Structure, Tertiary | 2 | 2012 | 797 | 0.040 |
Why?
| | Adaptation, Physiological | 1 | 2001 | 483 | 0.040 |
Why?
| | Autoantigens | 1 | 2000 | 397 | 0.040 |
Why?
| | Transfection | 2 | 2003 | 870 | 0.030 |
Why?
| | Cyclohexanes | 1 | 2016 | 22 | 0.030 |
Why?
| | Transduction, Genetic | 1 | 2016 | 113 | 0.030 |
Why?
| | Luminescent Measurements | 1 | 2016 | 74 | 0.030 |
Why?
| | Anilides | 1 | 2016 | 67 | 0.030 |
Why?
| | AC133 Antigen | 1 | 2015 | 19 | 0.030 |
Why?
| | High-Throughput Nucleotide Sequencing | 1 | 2019 | 441 | 0.030 |
Why?
| | Nitriles | 1 | 2016 | 151 | 0.030 |
Why?
| | Benzamides | 1 | 2016 | 169 | 0.030 |
Why?
| | Recombinant Proteins | 2 | 2003 | 1233 | 0.030 |
Why?
| | Proto-Oncogene Proteins c-mdm2 | 1 | 2015 | 56 | 0.030 |
Why?
| | Tumor Protein p73 | 1 | 2015 | 14 | 0.030 |
Why?
| | Fibroblasts | 1 | 2020 | 839 | 0.030 |
Why?
| | Polymerase Chain Reaction | 1 | 1998 | 995 | 0.030 |
Why?
| | Cell Count | 1 | 2015 | 305 | 0.030 |
Why?
| | Weight Gain | 1 | 2018 | 451 | 0.030 |
Why?
| | Aurora Kinase A | 1 | 2015 | 52 | 0.030 |
Why?
| | Hormone Antagonists | 1 | 1995 | 33 | 0.030 |
Why?
| | Software | 1 | 2019 | 537 | 0.030 |
Why?
| | TATA Box | 1 | 1994 | 22 | 0.030 |
Why?
| | Mammary Tumor Virus, Mouse | 1 | 1994 | 41 | 0.030 |
Why?
| | Adipose Tissue | 1 | 2018 | 538 | 0.030 |
Why?
| | Drug Synergism | 1 | 1994 | 316 | 0.030 |
Why?
| | Amino Acid Motifs | 2 | 2006 | 198 | 0.030 |
Why?
| | Promegestone | 1 | 1993 | 33 | 0.030 |
Why?
| | beta-Galactosidase | 1 | 1993 | 62 | 0.030 |
Why?
| | Wolves | 1 | 2012 | 1 | 0.030 |
Why?
| | Raccoon Dogs | 1 | 2012 | 1 | 0.030 |
Why?
| | Foxes | 1 | 2012 | 3 | 0.030 |
Why?
| | Cell Line | 2 | 2001 | 2640 | 0.030 |
Why?
| | Oligodeoxyribonucleotides | 1 | 1993 | 138 | 0.030 |
Why?
| | DNA | 2 | 2001 | 1351 | 0.030 |
Why?
| | Acitretin | 1 | 2012 | 3 | 0.030 |
Why?
| | Miconazole | 1 | 2012 | 4 | 0.030 |
Why?
| | CHO Cells | 1 | 2012 | 138 | 0.030 |
Why?
| | Isotretinoin | 1 | 2012 | 22 | 0.030 |
Why?
| | Cricetinae | 1 | 2012 | 254 | 0.030 |
Why?
| | Male | 3 | 2016 | 55655 | 0.030 |
Why?
| | Phosphates | 1 | 1993 | 158 | 0.030 |
Why?
| | Luciferases | 1 | 2012 | 142 | 0.020 |
Why?
| | 3' Untranslated Regions | 1 | 2012 | 129 | 0.020 |
Why?
| | Glucose | 1 | 2016 | 897 | 0.020 |
Why?
| | Dogs | 1 | 2012 | 337 | 0.020 |
Why?
| | Claudins | 1 | 2011 | 24 | 0.020 |
Why?
| | Species Specificity | 1 | 2012 | 547 | 0.020 |
Why?
| | Liver | 1 | 2019 | 1634 | 0.020 |
Why?
| | Diet | 1 | 2018 | 1077 | 0.020 |
Why?
| | Amyloid Precursor Protein Secretases | 1 | 2011 | 73 | 0.020 |
Why?
| | Cohort Studies | 1 | 2020 | 4903 | 0.020 |
Why?
| | Selective Estrogen Receptor Modulators | 1 | 2010 | 26 | 0.020 |
Why?
| | Green Fluorescent Proteins | 1 | 2012 | 373 | 0.020 |
Why?
| | Immunoenzyme Techniques | 1 | 2010 | 195 | 0.020 |
Why?
| | Protein Processing, Post-Translational | 1 | 2012 | 399 | 0.020 |
Why?
| | Protein Kinase Inhibitors | 1 | 2015 | 796 | 0.020 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 929 | 0.020 |
Why?
| | Progesterone Congeners | 1 | 2008 | 14 | 0.020 |
Why?
| | Microdissection | 1 | 2007 | 15 | 0.020 |
Why?
| | Blotting, Western | 1 | 2010 | 1151 | 0.020 |
Why?
| | Lasers | 1 | 2007 | 121 | 0.020 |
Why?
| | Nuclear Receptor Coactivator 1 | 1 | 2006 | 10 | 0.020 |
Why?
| | Lung | 1 | 2019 | 3593 | 0.020 |
Why?
| | Mutant Proteins | 1 | 2006 | 95 | 0.020 |
Why?
| | Protein Kinases | 1 | 2008 | 307 | 0.020 |
Why?
| | Protein Structure, Secondary | 1 | 2006 | 325 | 0.020 |
Why?
| | COS Cells | 1 | 2003 | 175 | 0.010 |
Why?
| | Analysis of Variance | 1 | 2005 | 1227 | 0.010 |
Why?
| | Mutagenesis | 1 | 2003 | 170 | 0.010 |
Why?
| | Sequence Alignment | 1 | 2003 | 325 | 0.010 |
Why?
| | Uterus | 1 | 2003 | 193 | 0.010 |
Why?
| | Sequence Deletion | 1 | 2001 | 168 | 0.010 |
Why?
| | Hypertrophy | 1 | 2001 | 111 | 0.010 |
Why?
| | Protein Binding | 1 | 2006 | 1897 | 0.010 |
Why?
| | Enhancer Elements, Genetic | 1 | 2001 | 152 | 0.010 |
Why?
| | Organ Size | 1 | 2001 | 435 | 0.010 |
Why?
| | Reference Values | 1 | 2001 | 741 | 0.010 |
Why?
| | Aged | 1 | 2015 | 19120 | 0.010 |
Why?
| | Body Weight | 1 | 2001 | 868 | 0.010 |
Why?
| | Motor Activity | 1 | 2001 | 641 | 0.010 |
Why?
| | Middle Aged | 1 | 2015 | 26801 | 0.010 |
Why?
| | Feeding Behavior | 1 | 2001 | 572 | 0.010 |
Why?
| | Membrane Proteins | 1 | 2001 | 1022 | 0.010 |
Why?
|
|
Sartorius's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|